Welcome to the RadNet Newsroom

The Cancer Research Collaboration, a non-profit organization dedicated to expanding the availability of cutting-edge cancer research, in partnership with RadNet, a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, are, once again, proud to work in conjunction with Blue Mesa Health’s Transform diabetes prevention program.

Visit RadNet at Booth #2129 at the 2018 Annual Meeting of the Radiological Society of North America (RSNA). This year RadNet is expanding its presentation of strategic imaging solutions. RadNet leverages a comprehensive portfolio of resources for its partners—as well as for patients and providers—to drive medical imaging innovations. RSNA attendees can learn more at Booth #2129.

LOS ANGELES, Nov. 09, 2018 (GLOBE NEWSWIRE) --  RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 341 (adjusted for centers added on October 1, 2018 related to the previously announced Medical Arts Imaging and EmblemHealth transactions) owned and/or operated outpatient imaging centers, today reported financial results for its third quarter of 2018.

Susan Hollabaugh, VP of Regulatory Analysis and Conformance for RadNet, will present on Blockchain at the upcoming AHRA Virtual Conference.

LOS ANGELES, Oct. 26, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its third quarter 2018 financial results on Friday, November 9^th, 2018 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).